Vnitr Lek 2013, 59(3):214-217

Diabetic retinopathy in the Czech National Diabetes Programme 2012-2022

T. Pelikánová
Centrum diabetologie IKEM Praha, přednostka prof. MUDr. Terezie Pelikánová, DrSc.

Diabetic retinopathy (DR) develops in patients with both type 1 and type 2 diabetes and is the major cause of vision loss and blindness in people of working age. In the Czech Republic, the number of patients with diabetic retinopathy is still increasing as well as the number of diabetic patients. It is known, that the comprehensive preventive and therapeutic procedures reduce the risk of visual loss by more than 90%. These procedures include intervention of modifiable risk factors (especially hypertension and hyperglycaemia), active screening of DR and specialized ophthalmologic treatment. The Czech National Diabetes Programme 2012-2022, which is built on similar initiatives as in 1984 and 2000, has been completed in late 2012. Its main goal is to improve the health outcomes for people diabetes in the Czech Republic. The programme includes specific procedures aimed at improvement of organization and treatment providing to patients with diabetic retinopathy.

Keywords: diabetic retinopathy; organization of health care

Received: January 28, 2013; Published: March 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pelikánová T. Diabetic retinopathy in the Czech National Diabetes Programme 2012-2022. Vnitr Lek. 2013;59(3):214-217.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ústav zdravotnických informací a statistiky. Péče o nemocné s cukrovkou 2011, Praha 2012 (www.uzis.cz).
    2. Kalvodová B, Sosna T, Řehák J et al za výbory České diabetologické společnosti a České oftalmologické společnosti. Doporučené postupy pro diagnostiku a léčbu diabetické retinopatie. DMEV 2012; 15: 30-34 (www.diab.cz).
    3. Česká diabetologická společnost ČLS JEP, Diabetická asociace ČR, Společnost všeobecných lékařů ČLS JEP. Národní diabetologický program 2012-2022. DMEV 2012; 15: 179-197 (www.diab.cz).
    4. Škrha J za výbor České diabetologické společnosti ČLS JEP. Epidemiologická studie o diabetes mellitus v České republice. Porovnání výsledků z roku 2002 a 2006. DMEV 2010; 13: 55-62.

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.